ArticleScientific reports2026
Ferroptosis inhibits biological behaviors of glioma cells by downregulating Galectin-9 transcriptional level via extracellular Acetyl-HMGB1.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Ferroptosis, the most common programmed cell death process, and immune checkpoints play increasingly prominent roles in glioma. However, the effects of ferroptosis on immune checkpoints on glioma remain unclear. The intracellular ROS levels of ferroptotic glioma cells were observed via fluorescence microscopy. The extracellular Acetyl-HMGB1 content of ferroptotic glioma cells was detected via an ELISA kit. Transwell chambers (8.0 μm) were used to detect the invasion ability of ferroptotic glioma cells. The ability of ferroptotic glioma cells to proliferate was detected via the CCK-8 reagent. The apoptosis of ferroptotic glioma cells was detected via an Annexin V-FITC apoptosis kit. The transcriptional levels of four immune checkpoints (CD80, CD155, HMGB1, and galectin-9) in ferroptotic glioma cells were detected via RT-PCR. Ferroptosis in glioma cells promotes the release of acetyl-HMGB1 and autophagy is involved in this process. Inhibiting extracellular acetyl-HMGB1 while inducing ferroptosis promoted the invasion and proliferation of glioma cells and inhibited apoptosis. Ferroptosis downregulated the transcription of CD155 and galectin-9 in glioma cells, but inhibition of extracellular acetyl-HMGB1 reversed the effect of ferroptosis on the downregulation of galectin-9 transcription. In conclusion, ferroptosis downregulates galectin-9 transcription via extracellular acetyl-HMGB1, thereby inhibiting the biological behavior of glioma cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.